MoonLake Immunotherapeutics (MLTX)

54.41 +2.55 (+4.92%) USD  |  NASDAQ  |  Nov 22, 14:09
More

MoonLake Immunotherapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for MLTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Return on Net Operating Assets Data

View and export this data back to . Upgrade now.
Date Value

Return on Net Operating Assets Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

Novartis AG Upgrade
AC Immune SA Upgrade
CRISPR Therapeutics AG --
Addex Therapeutics Ltd Upgrade
NLS Pharmaceutics Ltd --